You're viewing a public preview of Aardvark Therapeutics - ARD-301 Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Aardvark Therapeutics - ARD-301

Inactive
San Diego,  California (CA),  92130,  United States
Sector: Life Science Entity: Private
Merged Aardvark Therapeutics - ARD-301 merged into Sorrento Therapeutics, Inc., SCILEX Pharmaceuticals, Inc. in 2021
2
Transactions
Sign up to view
About Aardvark Therapeutics - ARD-301
Aardvark Therapeutics - ARD-301 is a privately held company operates in the Life Science sector. The company is headquartered in San Diego, California (CA). Aardvark Therapeutics - ARD-301 operates within the Life Science industry.
Investors
Current Investors
Sorrento Therapeutics, Inc. SCILEX Pharmaceuticals, Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Aardvark Therapeutics - ARD-301 M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Aardvark Therapeutics - ARD-301 do?
Aardvark Therapeutics - ARD-301 is a privately held company operates in the Life Science sector. The company is headquartered in San Diego, California (CA). Aardvark Therapeutics - ARD-301 operates within the Life Science industry.
Where is Aardvark Therapeutics - ARD-301 headquartered?
Aardvark Therapeutics - ARD-301 is headquartered in San Diego, California (CA), United States.
When was Aardvark Therapeutics - ARD-301 founded?
Founded year information for Aardvark Therapeutics - ARD-301 is available on AcquityData.
What sector is Aardvark Therapeutics - ARD-301 in?
Aardvark Therapeutics - ARD-301 operates in the Life Science sector.
Who are the investors in Aardvark Therapeutics - ARD-301?
Current investors in Aardvark Therapeutics - ARD-301 include Sorrento Therapeutics, Inc., SCILEX Pharmaceuticals, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Aardvark Therapeutics - ARD-301 been involved in?
Aardvark Therapeutics - ARD-301 has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Aardvark Therapeutics - ARD-301 profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Aardvark Therapeutics - ARD-301's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial